• Your search
    starts here.

    Whether you're looking for answers or a second opinion, put one of the world's leading cancer care centers to work for you.


    Search adult cancer typesSearch pediatric cancer types  

    Make an appointment
    with our care specialists.

    Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

    Adult 877-442-3324

    Pediatric 888-733-4662

    Make an Appointment Online  
  • flex image

    Innovation

    Ground-breaking research
    starts on our grounds.

    For nearly 70 years, we’ve led the world by making life-changing breakthroughs in cancer research and patient care. Each year, patients cross the globe to receive the most advanced care available, including over 700 innovative clinical trials. Our sole mission is to defeat cancer, especially yours.

    Research at dana-farber
    Find a Clinical Trial  

Newsroom

Matthew S. Davids, MD, MMSc

Dana-Farber at ASH 2016

December 3–6, 2016

As leaders in blood and blood cancer research, physicians and scientists from Dana-Farber Cancer Institute and Dana-Farber/Boston Children's Cancer and Blood Disorders Center showcased their advances at the 58th Annual Meeting of the American Society of Hematology (ASH) in San Diego.

 

Blog

pancreatic cancer cells

Can Immunotherapy Help Patients with Pancreatic Cancer?

November 30, 2016

Brian Wolpin, MD, MPH, and other scientists at Dana-Farber are testing immunotherapy combinations for pancreatic cancer and devising innovative strategies they hope will bring greater success to this difficult-to-treat disease.

 

Research

Precision Cancer Medicine - Nikhil Wagle, MD

New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation ...